|
|
||||||||
J Thorac Cardiovasc Surg 2003;126:983-991
© 2003 The American Association for Thoracic Surgery
Surgery for acquired cardiovascular disease |
a Cardiovascular Institute, Columbia-Presbyterian Medical Center, New York, NY, USA
b Universität Berlin Klinik für Kardiovasculare Chirurgie Charité Universitätsklinikum, Berlin, Germany
c Klinik für Innere Medizin, Unfallkrankenhaus Berlin, Berlin, Germany
d Klinik für Herzchirurgie, Herzzentrum Leipzig GmbH, Leipzig, Germany
e Herzchirurgische Abteilung, Allgemeines Krankenhaus St Georg, Hamburg, Germany
f Austin Repatriation Medical Centre, Heidelberg, Australia
g Hospital of the University of Pennsylvania, Philadelphia, Pa, USA
h The Cleveland Clinic Foundation, Cleveland, Ohio, USA
Received for publication May 13, 2002; revisions received October 21, 2002; accepted for publication October 23, 2002.
* Address for reprints: Mehmet C. Oz, MD, Columbia-Presbyterian Medical Center, 117 Ft Washington Ave, New York, NY 10032, USA
mco2{at}columbia.edu
OBJECTIVE: Surgical intervention is an option for treating the remodeled and dilated left ventricles of patients with heart failure. Providing end-diastolic support with an innovative mesh-like cardiac support device reduces mechanical stress, improves function, and reverses cardiac remodeling in animal models without safety issues. The objective of this study was to review the global clinical safety and feasibility experience of this device.
METHODS: The Acorn CorCap cardiac support device (Acorn Cardiovascular, Inc, St Paul, Minn) has been implanted worldwide in more than 130 patients with dilated cardiomyopathy with or without concomitant cardiac surgery. The device is positioned around the ventricles and given a custom fit. A series of 48 patients were implanted with the device in initial safety and feasibility studies, of whom 33 also received concomitant cardiac surgery.
RESULTS: At implantation, 11 patients were in New York Heart Association class II, 33 were in class III, and 4 were in class IV. The average CorCap implantation time was 27 minutes. The mean intraoperative reduction in left ventricular end-diastolic dimension was 4.6% ± 1%. There were no device-related intraoperative complications. Eight early and 9 late deaths occurred during follow-up extending to 24 months. Actuarial survival was 73% at 12 months and 68% at 24 months. There were no device-related adverse events or evidence of constrictive disease, and coronary artery flow reserve was maintained. Ventricular chamber dimensions decreased, whereas ejection fraction and New York Heart Association class were improved in patients overall and in those patients implanted with the CorCap device without concomitant operations.
CONCLUSIONS: The CorCap device appears safe for patients with dilated cardiomyopathy. Randomized clinical trials are underway in Europe, Australia, and North America.
This article has been cited by other articles:
![]() |
A. P.-W. Lee, M. Acker, S. H. Kubo, S. F. Bolling, S. W. Park, C. J. Bruce, and J. K. Oh Mechanisms of Recurrent Functional Mitral Regurgitation After Mitral Valve Repair in Nonischemic Dilated Cardiomyopathy: Importance of Distal Anterior Leaflet Tethering Circulation, May 19, 2009; 119(19): 2606 - 2614. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Nicolini and T. Gherli Alternatives to transplantation in the surgical therapy for heart failure Eur. J. Cardiothorac. Surg., February 1, 2009; 35(2): 214 - 228. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Y. Szeto, R. C. Gorman, J. H. Gorman III, and M. A. Acker Ischemic Mitral Regurgitation Card. Surg. Adult, January 1, 2008; 3(2008): 785 - 802. [Full Text] |
||||
![]() |
N. Valli, L. Labrousse, P. Reant, and P. Dos-Santos Significant improvement of cardiac sympathetic function following cardiac support device implantation: illustration by 123I-MIBG scintigraphy Eur. J. Cardiothorac. Surg., December 1, 2007; 32(6): 943 - 944. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Labrousse, L. Barandon, F. Numis, and C. Deville Parachute-like technique for off-pump implantation of cardiac support device in isolated and combined procedure Eur. J. Cardiothorac. Surg., November 1, 2007; 32(5): 807 - 809. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Mann, M. A. Acker, M. Jessup, H. N. Sabbah, R. C. Starling, and S. H. Kubo Clinical Evaluation of the CorCap Cardiac Support Device in Patients With Dilated Cardiomyopathy Ann. Thorac. Surg., October 1, 2007; 84(4): 1226 - 1235. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. B Friedrich and M. Bohm MANAGEMENT OF END STAGE HEART FAILURE Heart, May 1, 2007; 93(5): 626 - 631. [Full Text] [PDF] |
||||
![]() |
K. Serri, L. Labrousse, P. Reant, S. Lafitte, and R. Roudaut Significant improvement of myocardial function following cardiac support device implantation: Illustration by two-dimensional strain Eur J Echocardiogr, December 1, 2006; 7(6): 473 - 475. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Christiansen and R. Autschbach Doxorubicin in experimental and clinical heart failure. Eur. J. Cardiothorac. Surg., October 1, 2006; 30(4): 611 - 616. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Suma, T. Isomura, T. Horii, and F. Nomura Septal anterior ventricular exclusion procedure for idiopathic dilated cardiomyopathy. Ann. Thorac. Surg., October 1, 2006; 82(4): 1344 - 1348. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Horii, H. Suma, T. Isomura, F. Nomura, and J. Hoshino Left ventricle volume affects the result of mitral valve surgery for idiopathic dilated cardiomyopathy to treat congestive heart failure. Ann. Thorac. Surg., October 1, 2006; 82(4): 1349 - 1355. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Acker, S. Bolling, R. Shemin, J. Kirklin, J. K. Oh, D. L. Mann, M. Jessup, H. N. Sabbah, R. C. Starling, S. H. Kubo, et al. Mitral valve surgery in heart failure: Insights from the Acorn Clinical Trial. J. Thorac. Cardiovasc. Surg., September 1, 2006; 132(3): 568 - 577.e4. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Cheng, T. C. Nguyen, M. Malinowski, F. Langer, D. Liang, G. T. Daughters, N. B. Ingels Jr, and D. C. Miller Passive Ventricular Constraint Prevents Transmural Shear Strain Progression in Left Ventricle Remodeling Circulation, July 4, 2006; 114(1_suppl): I-79 - I-86. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. N. Schroder, B. Lima, J. G. Rogers, and C. A. Milano Cardiac transplantation following ACORN CorCap device implantation. Eur. J. Cardiothorac. Surg., May 1, 2006; 29(5): 848 - 850. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Pilla, A. S. Blom, J. H. Gorman III, D. J. Brockman, J. Affuso, L. M. Parish, H. Sakamoto, B. M. Jackson, M. A. Acker, and R. C. Gorman Early Postinfarction Ventricular Restraint Improves Borderzone Wall Thickening Dynamics During Remodeling Ann. Thorac. Surg., December 1, 2005; 80(6): 2257 - 2262. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Feindt, U. Boeken, J.D. Schipke, J. Litmathe, N. Zimmermann, and E. Gams Ventricular constraint in dilated cardiomyopathy: A new, compliant textile mesh exerts prophylactic and therapeutic properties J. Thorac. Cardiovasc. Surg., October 1, 2005; 130(4): 1107 - 1107. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Enomoto, J. H. Gorman III, S. L. Moainie, B. M. Jackson, L. M. Parish, T. Plappert, A. Zeeshan, M. G. St. John-Sutton, and R. C. Gorman Early Ventricular Restraint After Myocardial Infarction: Extent of the Wrap Determines the Outcome of Remodeling Ann. Thorac. Surg., March 1, 2005; 79(3): 881 - 887. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |